Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region

Article English OPEN
Castellsagué, Xavier; Ault, Kevin A.; Bosch, F. Xavier; Brown, Darron; Cuzick, Jack; Ferris, Daron G.; Joura, Elmar A.; Garland, Suzanne M.; Giuliano, Anna R; Hernandez-Avila, Mauricio; Huh, Warner; Iversen, Ole-Erik; Kjaer, Susanne K.; Luna, Joaquin; Monsonego, Joseph; Muñoz, Nubia; Myers, Evan; Paavonen, Jorma; Pitisuttihum, Punnee; Steben, Marc; Wheeler, Cosette M.; Perez, Gonzalo; Saah, Alfred; Pitisuttihum, Punnee; Steben, Marc; Wheeler, Cosette M.; Perez, Gonzalo; Saah, Alfred; Luxembourg, Alain; Sings, Heather L; ... view all 31 authors
(2016)
  • Subject: Human papillomavirus | Cervical cancer | Cervical intraepithelial neoplasia | Adenocarcinoma in situ | Enfermedades | Papiloma | Neoplasmas | Adenocarcinoma in Situ | Wart Virus Vaccine | Adenocarcinoma In Situ | Age Distribution | Article | Condyloma Acuminatum | Genotype | Geographic Distribution | Health Program | Human | Human Papillomavirus Type 11 | Human Papillomavirus Type 16 | Human Papillomavirus Type 18 | Human Papillomavirus Type 31 | Human Papillomavirus Type 33 | Human Papillomavirus Type 45 | Human Papillomavirus Type 52 | Human Papillomavirus Type 58 | Human Papillomavirus Type 6 | Immunization | Infection Risk | Mixed Infection | Molecular Epidemiology | Nonhuman | Prevalence | Priority Journal | Systematic Review | Uterine Cervix Carcinoma In Situ | Virus Detection | Wart Virus | Adenocarcinoma | Adolescent | Adult | Asia | Classification | Europe | Female | Genetics | Isolation And Purification | Middle Aged | North America | Papillomaviridae | Randomized Controlled Trial (Topic) | South And Central America | Virology | Young Adult | Cervical Intraepithelial Neoplasia | Humans | Latin America | Randomized Controlled Trials As Topic

Background: We estimated the proportion of cervical intraepithelial neoplasia (CIN) cases attributed to 14 HPV types, including quadrivalent (qHPV) (6/11/16/18) and 9-valent (9vHPV) (6/11/16/18/31/33/45/52/58) vaccine types, by region. Methods: Women ages 15-26 and 24-4... View more
Share - Bookmark